Genomic predictor of complete response after chemoradiotherapy in rectal cancer

Affiliations

Editorial

Gyoung Tae Noh et al. Ann Transl Med. 2016 Dec.

. 2016 Dec;4(24):493.

doi: 10.21037/atm.2016.12.03.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer.
Sebio A, Salazar J, Páez D, Berenguer-Llergo A, Del Río E, Tobeña M, Martín-Richard M, Sullivan I, Targarona E, Balart J, Baiget M, Barnadas A. Sebio A, et al. Pharmacogenomics J. 2015 Feb;15(1):77-83. doi: 10.1038/tpj.2014.33. Epub 2014 Jul 15. Pharmacogenomics J. 2015. PMID: 25026457

1. Du CZ, Li J, Cai Y, et al. Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy. World J Gastroenterol 2011;17:2013-8. 10.3748/wjg.v17.i15.2013 - DOI - PMC - PubMed
1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46. 10.1056/NEJMoa010580 - DOI - PubMed
1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N Engl J Med 2004; 351:1731-40 10.1056/NEJMoa040694 - DOI - PubMed
1. Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-30. 10.1200/JCO.2009.22.0467 - DOI - PMC - PubMed
1. Rödel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-96. 10.1200/JCO.2005.02.1329 - DOI - PubMed